Price $59.49 |
Market Cap
140.89B
|
Sector Health Care |
Div. Growth
6.20%
|
|
P/E
-
|
P/B
2.87
|
P/S
4.05
|
Dividend %
2.90%
|
|
P/CF
-
|
P/FCF
14.9
|
Op. Cash Flow
12.76M
|
FCF
4.1
|
|
Op. Margin
15.00%
|
Net Margin
-1.60%
|
ROE
-1.30%
|
ROI
5.50%
|
|
ROA
-0.50%
|
EPS Growth
-102.70%
|
Current Ratio
1.6
|
Debt/Equity
84.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.41 | - | - | 54.3M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.39 | - | - | 38.6M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.23 | - | - | 48.8M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.84 | - | - | 13.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
